In regard to decreased entry into the circulation as HAVcR-1 is expressed in prostate glandular epithelial cells, it would be expected that, similarly to PSA, the disruption of the normal prostate architecture that occurs with prostate cancer progression would cause increased entry into the circulation [19]. The gene discussed is HAVCR1; the disease is prostate cancer.